the importance of the olympia trial for breast cancer patients
Published 6 years ago • 284 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:44
olympia: adjuvant olaparib in gbrcam, her2-negative, high-risk, early breast cancer
-
2:58
olympia: adjuvant olaparib following chemo significantly improves idfs
-
6:28
quality of life results from olympia
-
3:05
exploring the use of olaparib in advanced breast cancer
-
3:35
the benefits of adjuvant cdk4/6 and parp inhibition in breast cancer
-
0:51
how does olaparib affect the quality of life of breast cancer patients?
-
3:09
breast cancer breakthrough - prof andrew tutt on the olympia trial
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
4:21
embraca & olympiad: targeting dna repair
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
5:00
olympia: adjuvant olaparib delays recurrence of brca-mutant breast cancer | judy garber
-
6:16
asco 2021 - highlights on shifting parpi to early breast cancer: the olympia study
-
2:40
update on study 19 trial of olaparib in serous ovarian cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
1:21
the challenges of treatment sequencing in hr breast cancer patients
-
1:45
the olympia clinical trial - results
-
1:14
the olympia breast cancer clinical trial - breast cancer trials
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
1:04
strategies to improve wellbeing in breast cancer patients